CONTINENTAL STRATEGY, LLC

Lobbying for VIVEX BIOLOGICS · regenerative medicine company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Florida · $120,000.00 income · posted Apr 18, 2026

Lobbying activity 2

Science/Technology

regenerative and innovative medical solutions

Health Issues

regenerative and innovative medical solutions

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.